Drugs / PRP
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT04088227 | Sep 2019 → Sep 2022 | — | Andrews Research & Education Foundation | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PRP | “The purpose of this pilot randomized controlled trial was to evaluate the preoperative effect of a 2-injection series of platelet-rich plasma (PRP) on the progression of...” PMID 40052182 ↗ Mar 2025 |
| Action | Inhibit | “Platelet rich plasma decreases synoviocyte production of metallometal proteases” NCT04088227 ↗ |
| Modality | Other / unclassified | “Platelet rich plasma is an autologous derived blood product” NCT04088227 ↗ |